This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Emerging Infectious Diseases (journal) | |
|---|---|
| Title | Emerging Infectious Diseases |
| Abbreviation | EID |
| Discipline | Infectious diseases, Epidemiology, Public health |
| Publisher | Centers for Disease Control and Prevention |
| Country | United States |
| History | 1995–present |
| Frequency | Monthly |
| Issn | 1080-6040 |
Emerging Infectious Diseases (journal) is a peer-reviewed, open-access medical journal published by the Centers for Disease Control and Prevention that focuses on the epidemiology, prevention, and control of emerging infectious diseases. The journal serves as a forum for clinicians, epidemiologists, microbiologists, and public health officials from institutions such as the World Health Organization, Pan American Health Organization, and national public health agencies including the Public Health Agency of Canada and the European Centre for Disease Prevention and Control. It intersects with topics addressed by organizations like the Bill & Melinda Gates Foundation, research programs at the National Institutes of Health, and academic centers such as Johns Hopkins University and the Harvard T. H. Chan School of Public Health.
Launched in 1995 during an era marked by renewed attention to zoonotic and antimicrobial-resistant pathogens, the journal emerged alongside heightened global responses to outbreaks such as the 1993 hantavirus pulmonary syndrome event in the Four Corners (region) and later episodes including the Severe acute respiratory syndrome outbreak. Its inception paralleled initiatives by the Institute of Medicine (United States) and the publication of influential reports on emerging infections, with editorial and operational links to federal entities like the U.S. Congress through appropriations and oversight tied to public health preparedness. Throughout its history the journal has documented pandemics and epidemics involving agents such as HIV/AIDS pandemic, Ebola virus epidemic in West Africa, Zika virus epidemic, 2009 swine flu pandemic, and the COVID-19 pandemic, contributing to archival and policy discussions that engaged stakeholders from the Gavi, the Vaccine Alliance to the Food and Agriculture Organization.
The journal publishes original research, surveillance reports, clinical observations, and policy analyses that address pathogen emergence, reemergence, and spread across human, animal, and environmental interfaces. Its topical remit encompasses studies on pathogens like Mycobacterium tuberculosis, Plasmodium falciparum, H5N1 influenza, SARS-CoV-2, Ebola virus, Lassa virus, and Chikungunya virus, as well as investigations into antimicrobial resistance including methicillin-resistant Staphylococcus aureus and carbapenem-resistant Enterobacteriaceae. The journal frequently features interdisciplinary work connecting laboratories at the Centers for Disease Control and Prevention with research groups at institutions such as the University of Oxford, University of Cambridge, Wellcome Trust, and regional centers like the Kenya Medical Research Institute.
Editorial oversight has been provided by senior public health scientists affiliated with federal agencies and academia, reflecting collaborations among professionals from the National Center for Emerging and Zoonotic Infectious Diseases, the U.S. Department of Health and Human Services, and international partners including the European Union research networks. The journal employs external peer reviewers drawn from specialist communities at institutions such as the London School of Hygiene & Tropical Medicine, CDC reference laboratories, and university departments at Stanford University, Yale School of Medicine, and the University of California, Berkeley. Its peer-review process aligns with standards advocated by bodies like the International Committee of Medical Journal Editors and expects disclosure practices consistent with guidelines from organizations such as the Committee on Publication Ethics.
Published monthly, the journal offers an online, open-access format that includes sections for dispatches, research articles, systematic reviews, policy perspectives, and technical notes. It complements its articles with visual elements such as maps and infographics produced in collaboration with design teams and illustrators, echoing practices seen in periodicals produced by institutions like the National Geographic Society and scientific publishers including Elsevier and Springer Nature. Special thematic issues and supplements have addressed outbreak response, vaccine development programs featuring entities like Moderna, Inc. and Pfizer, and One Health initiatives involving the World Organisation for Animal Health.
The journal is abstracted and indexed in major bibliographic databases and citation services used by researchers at organizations such as the National Library of Medicine, PubMed Central, Scopus, and the Web of Science. Its inclusion in these repositories ensures discoverability alongside literature from publishers such as Oxford University Press and Cambridge University Press, and integration with bibliometric tools employed by universities including Massachusetts Institute of Technology and University of California campuses.
The journal has been cited widely across public health, clinical medicine, and policy literature, influencing responses by agencies like the World Health Organization and national ministries of health in countries including China, Brazil, South Africa, and India. Its reporting on events such as the Ebola virus epidemic in West Africa and the COVID-19 pandemic has been referenced in guidance from the U.S. Food and Drug Administration and in research funded by the Wellcome Trust and the National Science Foundation (United States). Review editors and commentators from academic institutions including Columbia University and University College London have noted the journal’s role in rapid dissemination during public health emergencies.
The journal’s archive includes influential pieces on pathogen discovery, genomic epidemiology, and outbreak investigation methods, with articles addressing topics like phylogenetic tracing used in analyses by teams at the Broad Institute, vaccine effectiveness studies linked to trials run by GlaxoSmithKline and AstraZeneca, and surveillance reports from national reference laboratories such as those in Nigeria and Thailand. Contributions have intersected with landmark reports from the Centers for Disease Control and Prevention and global assessments by the World Health Organization, informing strategies in antimicrobial stewardship promoted by organizations including the Global Antibiotic Research and Development Partnership.
Category:Medical journals Category:Public health journals Category:Open access journals